U.S. Should Increase Awareness Of, Funding For NTD Eradication

The Conversation: Why aren’t we curing the world’s most curable diseases?
Katherine J. Wu, Ph.D. candidate in microbiology at Harvard University

“…Even with all the necessary tools, the world has failed to cure the curable. One-and-a-half billion people across the world suffer from neglected tropical diseases … At least eight of these [13] diseases, including river blindness, already have inexpensive, safe, and effective treatments or interventions. For less than 50 cents per person, the United States could cure a fifth of the world’s population of these severely debilitating and unnecessary diseases. In spite of this, the United States allocates nearly as little to treating and preventing neglected tropical diseases around the world as it does to drugs for erectile dysfunction. … Funding from the U.S. and other countries could help in the final push to eradication, and some argue that funding from the individual countries themselves could help. … By increasing awareness and funding of neglected tropical disease eradication, the United States will be making one of the best global investments possible. The rest of the world has waited long enough” (10/24).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.